Intratumoral injection of STING agonists into tumor‐bearing mice (cGAMP or ADU‐S100) upregulated type I/II IFN genes, vascular stabilizing genes (including Angpt1, Pdgfrb, and Col4a), and adhesion molecules (including Icam, Vcam, and Sell), promoted tumor vascular normalization, reduced tumor hypoxia, and increased tumor‐specific CTL infiltration.287. This evidence concerns the gene STING1 and neoplasm.